ACP
HALO icon

Arrowgrass Capital Partners’s Halozyme HALO Stock Holding History

Arrowgrass Capital Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-22,000
Closed -$212K – 27
2014
Q4 		$212K Hold
22,000
– – 0.06% 10
2014
Q3 		$200K Hold
22,000
– – 0.05% 9
2014
Q2 		$217K Hold
22,000
– – 0.05% 12
2014
Q1 		$280K Buy
+22,000
New +$327K 0.09% 21

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowgrass Capital Partners's HALO Position: Q1 2015 in Review

Arrowgrass Capital Partners sold out of Halozyme (HALO) in Q1 2015, closing a stake of 22,000 shares — an estimated $212K sold.

Arrowgrass Capital Partners first reported a position in HALO in Q1 2014 and held it in 4 quarters. The position peaked at $280K in Q1 2014. 137 funds tracked by Wall St. Rank hold HALO as of Q1 2015.

  • Arrowgrass Capital Partners reported no remaining Halozyme position as of Q1 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners sold 22,000 Halozyme shares in Q1 2015, an estimated $212K.
  • Arrowgrass Capital Partners first reported a position in Halozyme in Q1 2014 and held it in 4 quarters.
  • Arrowgrass Capital Partners's Halozyme position peaked at $280K in Q1 2014.
  • 137 funds tracked by Wall St. Rank held Halozyme as of Q1 2015.

Based on Arrowgrass Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.